These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 14725493)

  • 1. Insulin inhalation: NN 1998.
    Drugs R D; 2004; 5(1):46-9. PubMed ID: 14725493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compliance with inhaled insulin treatment using the AERx iDMS Insulin Diabetes Management System.
    Cramer JA; Okikawa J; Bellaire S; Clauson P
    Diabetes Technol Ther; 2004 Dec; 6(6):800-7. PubMed ID: 15684632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivering needle-free insulin using AERx iDMS (insulin diabetes management system) technology.
    Wollmer P; Pieber TR; Gall MA; Brunton S
    Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S57-64. PubMed ID: 17563305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524.
    Drugs R D; 2007; 8(2):103-12. PubMed ID: 17324008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
    Drugs R D; 2005; 6(2):120-7. PubMed ID: 15777106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab.
    BioDrugs; 2003; 17(4):290-5. PubMed ID: 12899647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin inhalation--Pfizer/Nektar Therapeutics: HMR 4006, inhaled PEG-insulin--Nektar, PEGylated insulin--Nektar.
    Drugs R D; 2004; 5(3):166-70. PubMed ID: 15139780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive therapy with inhaled insulin via the AERx insulin diabetes management system: a 12-week proof-of-concept trial in patients with type 2 diabetes.
    Hermansen K; Rönnemaa T; Petersen AH; Bellaire S; Adamson U
    Diabetes Care; 2004 Jan; 27(1):162-7. PubMed ID: 14693983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amoxicillin pulsatile - MiddleBrook: APC 111, APC-111, PULSYS-enhanced amoxicillin.
    Drugs R D; 2007; 8(6):395-9. PubMed ID: 17963430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled insulin using AERx insulin Diabetes Management System (AERx iDMS).
    Mudaliar S
    Expert Opin Investig Drugs; 2007 Oct; 16(10):1673-81. PubMed ID: 17922630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled insulin--does it become reality?
    Siekmeier R; Scheuch G
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():81-113. PubMed ID: 19218634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled insulin using the AERx Insulin Diabetes Management System in healthy and asthmatic subjects.
    Henry RR; Mudaliar SR; Howland WC; Chu N; Kim D; An B; Reinhardt RR
    Diabetes Care; 2003 Mar; 26(3):764-9. PubMed ID: 12610035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
    Drugs R D; 2005; 6(3):178-85. PubMed ID: 15869322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary insulin administration using the AERx system: physiological and physicochemical factors influencing insulin effectiveness in healthy fasting subjects.
    Farr SJ; McElduff A; Mather LE; Okikawa J; Ward ME; Gonda I; Licko V; Rubsamen RM
    Diabetes Technol Ther; 2000; 2(2):185-97. PubMed ID: 11469258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rubitecan: 9-NC, 9-Nitro-20(S)-camptothecin, 9-nitro-camptothecin, 9-nitrocamptothecin, RFS 2000, RFS2000.
    Drugs R D; 2004; 5(5):305-11. PubMed ID: 15357630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients.
    Brunner GA; Balent B; Ellmerer M; Schaupp L; Siebenhofer A; Jendle JH; Okikawa J; Pieber TR
    Diabetologia; 2001 Mar; 44(3):305-8. PubMed ID: 11317660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrasubject variability of inhaled insulin in type 1 diabetes: a comparison with subcutaneous insulin.
    Kapitza C; Hompesch M; Scharling B; Heise T
    Diabetes Technol Ther; 2004 Aug; 6(4):466-72. PubMed ID: 15321001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Satraplatin: BMS 182751, BMY 45594, JM 216.
    Drugs R D; 2007; 8(2):125-32. PubMed ID: 17324011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.